dame sally davies says genome testing is still a cottage industry.rm for cancer patients within five years. patients will benefit if we can offer them the scan of their genome that'll make a difference to their treatment. that's clearly all people with rare diseases, of whom there are three million or more in this country. it's most patients with cancers, and quite a lot of infections. 0ur genome contains the instructions for how our bodies work. errors in the dna code can trigger disease. six out of ten cancer patients who have genome analysis can benefit from targeted treatment — drugs which attack dna faults in their tumours. this can spare them the more toxic side effects of chemotherapy. it costs £680 to scan a genome, and that price is falling every few months. in some cases, it's now cheaper than existing tests, like invasive biopsies. but what about data confidentiality? the nhs believes it can protect genomic information, but some are concerned about the safeguards. if you're going to take a lot of very sensitive information from people, the

dame sally davies says genome testing is still a cottage industry.tients within five years. patients will benefit if we can offer them the scan of their genome that'll make a difference to their treatment. that's clearly all people with rare diseases, of whom there are 3 million or more in this country. it's most patients with cancers, and quite a lot of infections. 0ur genome contains the instructions for how our bodies work. errors in the dna code can trigger disease. six out of ten cancer patients who have genome analysis can benefit from targeted treatment — drugs which attack dna faults in their tumours. this can spare them the more toxic side effects of chemotherapy. it costs £680 to scan a genome, and that price is falling every few months. in some cases, it's now cheaper than existing tests, like invasive biopsies. but what about data confidentiality? the nhs believes it can protect genomic information, but some are concerned about the safeguards. if you're going to take a lot of sensitive information from people, then you need to make sure t

dame sally davies says genome testing is still a cottage industry.nts within five years. patients will benefit if we can offer them the scan of their genome that'll make a difference to their treatment. that's clearly all people with rare diseases, of whom there are 3 million or more in this country. it's most patients with cancers, and quite a lot of infections. 0ur genome contains the instructions for how our bodies work. errors in the dna code can trigger disease. six out of ten cancer patients who have genome analysis can benefit from targeted treatment — drugs which attack dna faults in their tumours. this can spare them the more toxic side—effects of chemotherapy. it costs £680 to scan a genome, and that price is falling every few months. in some cases, it's now cheaper than existing tests, like invasive biopsies. but what about data confidentiality? the nhs believes it can protect genomic information, but some are concerned about the safeguards. if you're going to take a lot of sensitive information from people, then you need to make sure that

professor dame sally davies is calling for a national network of genome testing.ts who get gene tested receive better care as a result and she wants it to become standard practice across cancer care, as well as some other areas of medicine, including rare diseases and infections. here's our medical correspondent, fergus walsh. inside nearly every cell in our body is our genome, the dna instructions for life. errors in the code can trigger cancer or other diseases. cancer runs in kobe's family. both his parents died from it and he was diagnosed with: cancer four years ago. now he is one of 31,000 patients who have had their entire genome mapped by the nhs. i am very excited about it. for me, hopefully, if my cancer decides to come back, it will benefit me. more importantly, it will benefit a lot of other people in future for better treatments, quicker treatments, better diagnosis. dame sally davies says genome testing is still a cottage industry, she wants dna analysis to be the norm for cancer patients within five years. patients will benefit if we can offer them

dame sally davies says her ‘genomic dream' must be delivered by the nhs within five years.e can trust" and that sir martin moore—bick lacked "credibility" with the families. the high court rules that the human rights of a 16—year—old boy with "significant mental health problems" were breached, after he was held alone in a cell for up to 23 and a half hours a day at a young offenders' institute. north korea says it has successfully launched an intercontinental ballistic missile. the range seems to have been much greater than in previous tests. if the claim is true the missile could potentially have the range to reach parts of the united states. we can talk now to professor hazel smith from the centre of korean studies at the school of oriental and african studies. thank of oriental and african studies. you forjoining us. significant thank you forjoining us. how significant you think this launch is? what it represents is the continuing militarisation of east asia, the continuing technical development in missile and nuclear technology of north korea and it shows also that we s

england's chief medical officer, professor dame sally davies is behind the plan and joins us from central0% or more of cases, two thirds, we see changes in the cancer gene known which tells us something about the best way to treat those patients. sometimes it says they don't need strong, heavy, nasty treatment. sometimes they say, "there is a treatment here that will work well. sometimes it says don't go to that treatment, they will get nasty side—effects. already, our genome project is showing us we can do this and two thirds of patients will benefit. what we need to do now is change how we deliver our services. at the moment, we have genetic services genomics built up where the scientists are and the regional genetic services are. i wa nt to regional genetic services are. i want to bring science to patients, democratise it and make sure we have a national service so patients everywhere can get access to treatments that will make a difference. i am sure you are aware that whenever we talk about health on this programme, we must talk about cost as well. part of this mapping process compar

professor dame sally davies is calling for a national network of genome testing.e wants this to become standard practice across cancer care, and some other areas of medicine like rare diseases and infections. 0ur medical correspondent, fergus walsh, explains. inside nearly every cell in our body is our genome, the dna instructions for life. errors in the code can trigger cancer or other diseases. cancer runs in toby knight's family. both his parents died from it and he was diagnosed with colon cancer four years ago. now he is one of 31,000 patients who have had their entire genome mapped by the nhs. i am very excited about it. for me, hopefully, if my cancer decides to come back it will benefit me. more importantly it will benefit a lot of other people, forfuture generations, for better treatments, for quicker treatments, better diagnoses. dame sally davies says genome testing is still a cottage industry — she wants dna analysis to be the norm for cancer patients within five years. patients will benefit if we can offer them the scan of their genome that'll make a

in her annual report professor dame sally davies says the "genomics dream" would see millions of patientsments. the proposals have been welcomed by other health professionals. 0ur medical correspondent fergus walsh reports. more than 30,000 nhs patients, mostly with cancer or rare diseases, have had their entire genetic code mapped. some patients with cancer are having the genetic profile of their tumours analysed to determine which is the best treatment for them. sally told me thatjim rome testing needs to be turned into a national network, to ensure all patients have access —— genomic testing. patients need to be close to their treatments. all people with rare diseases, of whom there are at least 3 million off in this country. most patients with cancers and quite a lot of infections. she says six in ten cancer patients should get gene testing and receive the personalised treatment based on their dna profile. that abortion will rise. it costs £680 to map a person's genetic code, but it gets cheaper every few months —— gene. in some cases, it can be cheaper than existing tests 01’ can be

professor dame sally davies is calling for a national network of genome testing.e across cancer care, as well as some other areas of medicine, including rare diseases and infections. here's our medical correspondent fergus walsh. inside nearly every cell in our body is our genome, the dna instructions for life. errors in the code can trigger cancer or other diseases. cancer runs in toby knight's family. both his parents died from it and he was diagnosed with colon cancer four years ago. now he is one of 31,000 patients who have had their entire genome mapped by the nhs. i am very excited about it. for me, hopefully, if my cancer decides to come back it will benefit me. more importantly it will benefit a lot of other people, forfuture generations, for better treatments, for quicker treatments, better diagnoses. dame sally davies says genome testing is still a cottage industry — she wants dna analysis to be the norm for cancer patients within five years. patients will benefit if we can offer them the scan of their genome that'll make a difference to their treatment.

professor dame sally davies says mapping dna could lead to more personalised treatments for cancer, ands. patient confidentiality campaigners say the government isn't doing enough to keep such information secure. with me is toby knight — someone who knows how difficult and devastating cancer can be. toby is in support of dna mapping and is part of a project called 100,000 genomes. first of all, when i say you know personally, both your parents died from cancer. yes. and you yourself have been treated for it as well. for some reason it has gone down both sides of the family, there isn't a lot of cancer on either side, but it has decided to take more of a central route. my mum's dad died when he was 37, my dad died from leukaemia, and i had my turn in november 2000 13. from leukaemia, and i had my turn in november 200013. 50 from leukaemia, and i had my turn in november 2000 13. so why are from leukaemia, and i had my turn in november 200013. so why are you so keen on dna mapping? the more we can learn earlier on about genetic anomalies, why cells change, there isa anomalies, why cells ch

dame sally davies says that genome testing is still a cottage industry, she would like dna analysis toenefit if we can offer them the scan of their genome which will make a difference to treatment. that is clearly all people with rare diseases, of whom there are 3 million or more in this country. most patients with cancers, quite a lot of infections. it cost £680 to mapa lot of infections. it cost £680 to map a person's entire genetic code, it is getting cheaper every few months. in some cases, dna mapping can be cheaper than existing tests or avoid the need for invasive biopsies. but what about data confidentiality? the nhs believes it can protect genomic information. some are concerned about the safeguards. this report is an attempt to do not come —— democratise —— democratise genomics, moving it into the mainstream, so that more and more patients can benefit from personalised targeted treatment. not the first time on outside source, we will talk about the treatment of women in silicon valley, they've mcclure, silicon valley venture capitalist founded a firm called 500 start—ups and

but dame sally davies told me genome testing needs to be turned from a cottage industry into a nationalqual access. cost matters. of course it does. patients will benefit if we can offer them the scan of their genome that will make a difference to their treatments. that's clearly all people with rare diseases, of whom there are 3 million or more in this country. it's most patients with cancers and quite a lot of infections. dame sally says six in ten cancer patients who get gene tested receive personalised treatment based on their dna profile, and that proportion will rise. it costs £680 to map a person's entire genetic code, but it's getting cheaper every few months. in some cases, dna mapping can be cheaper than existing tests or avoid the need for invasive biopsies. this report is an attempt to democratise genomics, moving dna analysis into the mainstream of the nhs so that more and more patients can benefit from personalised, targeted treatments. fergus walsh, bbc news. joanna gosling is in the bbc newsroom with a summary of the rest of the day's news. north korea says it has succes